From 23 June 2025, the new weight-loss medication Tirzepatide (Mounjaro®) will be available on the NHS nationally.
However, please note it is NOT yet available locally—GPs in Lancashire and South Cumbria are not prescribing it at this time. Residents are advised not to contact their GP about it yet.
Eligibility criteria (as per NHS guidance) will be:
BMI ≥ 40 kg/m² (or ≥ 37.5 for some ethnic groups)
PLUS at least FOUR long-term conditions, such as type 2 diabetes, hypertension, dyslipidaemia, cardiovascular disease, obstructive sleep apnoea.
In the meantime, existing support services—like lifestyle programmes and digital tools—remain available.
If you have any questions, please contact the patient experience team: lscicb‑fw.patientexperience@nhs.net
More information can be found here using this link